tirzepatide oral vs injectable Rapid Dissolve Sublingual Tablets in Seattle, WA A lot of our patients

If approved in the EU, Sandoz could launch as early as 2028 in Europe

We incorporate these findings into a broader model of GLP1 medication response, and demonstrate the ability to stratify patients by efficacy and side effect risk

Currently approved options include: Semaglutide: Available as a weekly injection (Ozempic for type 2 diabetes, Wegovy for weight management) or a daily oral tablet (Rybelsus for type 2 diabetes)

This study adds supporting evidence of favorable renal effects with GLP-1RAs therapy in a real-world T2D population that had a relatively poor renal function

Burns LH, Pei Z, Wang H-Y

Higher doses produced better results, but only when reached through proper escalation